News Summary

On Thursday and Friday next week, the “Better Medicines for Children” Meeting (DIA/EFGCP) will take place in Brussels. EUCROF will be represented by its President, Martine Dehlinger-Kremer, its Vice-President, Dr Stefano Marini, together with Dr Dagmar Chase. Martine Dehlinger-Kremer will...

The Clinical Trial Facilitation Group (CTFG) Stakeholder Meeting will take place in Bonn on Wednesday, 24 October 2018. The meeting will develop the following topics:EUCROF will be attending, represented by Dr Stefano Marini and Dr Dagmar Chase.Kindly click on the...

Applied Clinical Trials published in its Volume 26, Issue 10, a paper called “The Shifting Perspectives on Pharmacovigilance in Europe” including some highlights and a link to the paper prepared by the EUCROF PharmacoVigilance Working Group on the EUCROF website.http://www.appliedclinicaltrialsonline.com/shifting-perspectives-pharmacovigilance-europe

According to recent GVP module VI Revision 2, from 22 NOV 2017 non-serious ADRs from the market in Europe should be submitted to EMA/Eudravigilance within 90 days. This new updated GVP module also applies to non-interventional studies.This may have an...

On 25 April 2017, EUCROF, represented by Dr Martine Dehlinger-Kremer, has been invited to speak about the new EU Clinical Trials Regulation at “Clinical  Trials in Central &Easter Europe Forum” in Budapest.

On 25 April 2017, EUCROF, represented by Dr Martine Dehlinger-Kremer, has been invited to speak about the new EU Clinical Trials Regulation at “Clinical  Trials in Central &Easter Europe Forum” in Budapest.

EUCROF, represented by Dr Martine Dehlinger-Kremer, will be speaking at the “International Pediatric Clinical Trial Day 2017 – Helping children create lives they deserve” on 09 May 2017 in Milan.

On 12 June 2017, EUCROF is going to attend as stakeholder the Good Clinical Practice Inspectors Working Group meeting on topics related to e-source data / EDC tools in clinical trials at the EMA in London.